Please refer to the appropriate section for further information about the Advanced Particle Engineering Technologies available from Prosonix and how specialized Sonocrystallization, UMAX^®, SAX^TM (Solution Atomisation and Crystallization by Sonication) and DISCUS^® (Dispersive Crystallisation with Ultrasound) and PRT (Particle Rounding Technology) represent the cutting edge in advanced API particle engineering and have the potential to transform inhalation and oral drug delivery.

For further information on our pharmaceutical research and development please refer to:

SAX | DISCUS | PRT |Sonocrystallization

For additional information relating to our pharmaceutical research & development please refer to:

Inhalation | Combination therapy |  Pharmaceutical Clients | FDA Quality by Design

Partner with Prosonix today.